论文部分内容阅读
目的探讨乌司他丁联合奥曲肽治疗重症胰腺炎的临床疗效。方法选择我院收治的82例重症胰腺炎患者,随机分为实验组及对照组,实验组42例给予乌司他丁联合奥曲肽治疗,对照组40例给予单独的奥曲肽治疗,对比分析两组患者的临床疗效。结果实验组患者的总有效率为97.62%,对照组患者的总有效率为85.0%,两组间的差异有显著性(P<0.05);实验组的血淀粉酶恢复时间、尿淀粉酶恢复时间、腹痛缓解时间及住院时间均明显少于对照组,两组比较差异具有显著性(P<0.01)。结论乌司他丁联合奥曲肽治疗重症胰腺炎相比单独使用奥曲肽的疗效显著,能有效缓解临床症状,值得在临床中推广。
Objective To investigate the clinical efficacy of ulinastatin combined with octreotide in the treatment of severe pancreatitis. Methods Eighty-two patients with severe acute pancreatitis admitted to our hospital were randomly divided into experimental group and control group. In the experimental group, 42 cases were treated with ulinastatin combined with octreotide, while 40 cases in control group were given octreotide alone. The clinical efficacy. Results The total effective rate was 97.62% in the experimental group and 85.0% in the control group, with significant difference between the two groups (P <0.05). The recovery time of blood amylase, urine amylase Time, abdominal pain relief time and hospitalization time were significantly less than the control group, the difference between the two groups was significant (P <0.01). Conclusion The effect of ulinastatin combined with octreotide on severe pancreatitis is better than that of octreotide alone. It can effectively relieve the clinical symptoms and is worth popularizing in clinic.